The compiler infers, but does not take instructions. There is no syntax for explicit type declarations yet, and the new type ...

The accessibility tree decides whether an AI agent can read and act on your page. The 2026 data says the web is getting ...

Richard Socher's new $650 million startup wants to build an AI that can research and improve itself indefinitely — and he insists it will actually ship products.

Thanks for attending the 2026 Bank of America Healthcare Conference. My name is Alec Stranahan. I cover Recursion and SMid Biotech at Bank of America. And I'm pleased to be joined today by Ben Taylor, ...

Abstract: This paper presents a mathematical framework for performance analysis of Behavior Trees (BTs). BTs are a recent alternative to Finite State Machines (FSMs), for doing modular task switching ...

conda create -n unifolm-wma python==3.10.18 conda activate unifolm-wma conda install pinocchio=3.2.0 -c conda-forge -y conda install ffmpeg=7.1.1 -c conda-forge git ...

A decision tree regression system incorporates a set of if-then rules to predict a single numeric value. Decision tree regression is rarely used by itself because it overfits the training data, and so ...

The original version of this story appeared in Quanta Magazine. Among the myriad abilities that humans possess, which ones are uniquely human? Language has been a top candidate at least since ...

Among the myriad abilities that humans possess, which ones are uniquely human? Language has been a top candidate at least since Aristotle, who wrote that humanity was “the animal that has language.” ...

Recursion – the process of a system feeding its outputs back into itself – is a powerful concept spanning systems theory, cognitive science, and artificial intelligence. In simple terms, recursive ...

Welcome everybody to Recursion's Earnings Call. I'm Chris Gibson, Co-Founder and CEO, and I'm excited to take you through Recursions 2024, 2025 and the time ahead. So with that we'll jump into the ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking innovations like mRNA cancer vaccines and CRISPR-based therapies. Structural ...